BioCryst Pharmaceuticals, Inc.
DE ˙ DB ˙ US09058V1035
7,01 € ↓ -0,21 (-2,88%)
2026-06-04
DEL PRIS
SecurityDE:BO1 / BioCryst Pharmaceuticals, Inc.
InstitutionPersonal Cfo Solutions, Llc
Latest Disclosed Ownership21,667 shares
Latest Disclosed Value $ 206,270
Personal Cfo Solutions, Llc reports 65.28% decrease in ownership of BO1 / BioCryst Pharmaceuticals, Inc.

On April 30, 2026 - Personal Cfo Solutions, Llc filed a 13F-HR form disclosing ownership of 21,667 shares of BioCryst Pharmaceuticals, Inc. (DE:BO1) valued at $178,103 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 62,400 shares of BioCryst Pharmaceuticals, Inc.. This represents a change in shares of -65.28% during the quarter. The current value of the position is $151,886 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 21,667 -40,733 -65.28 206 -57.61 0.0290
2026-01-22 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 62,400 212 0.34 487 2.97 0.0773
2025-11-10 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 62,188 0 0.00 472 -15.26 0.0828
2025-08-12 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 62,188 0 0.00 557 19.53 0.1031
2025-04-30 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 62,188 672 1.09 466 0.87 0.0947
2025-02-07 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 61,516 -215 -0.35 463 -1.49 0.0910
2024-11-14 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 61,731 0 0.00 469 23.10 0.0655
2024-08-09 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 61,731 -5,000 -7.49 381 12.72 0.0586
2024-05-13 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,731 428 0.65 339 -14.86 0.0529
2024-02-13 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,303 -453 -0.68 397 -15.89 0.0688
2023-11-13 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,756 0 0.00 473 0.64 0.0934
2023-08-10 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 66,756 -1,000 -1.48 470 -16.99 0.0954
2023-05-09 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 67,756 366 0.54 565 -26.91 0.1167
2023-02-14 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 67,390 0 0.00 774 -8.95 0.1638
2022-11-01 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 67,390 302 0.45 849 19.58 0.2132
2022-08-05 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 67,088 -42,100 -38.56 710 -60.00 0.1665
2022-05-02 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 109,188 0 0.00 1,775 17.39 0.3501
2022-02-11 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 109,188 0 0.00 1,512 -3.63 0.2830
2021-11-18 2021-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 109,188 -2,490 -2.23 1,569 -11.16 0.3215
2021-07-22 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 111,678 -10,000 -8.22 1,766 42.76 0.3616
2021-04-21 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 121,678 16,500 15.69 1,237 57.78 0.2674
2021-02-09 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 105,178 14,000 15.35 784 0.1940
2020-11-02 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 91,178 8,500 10.28 0 -100.00
2020-08-03 2020-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 82,678 -4,400 -5.05 394 126.44 0.1166
2020-04-30 2020-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 87,078 55,078 172.12 174 58.18 0.0625
2020-02-13 2019-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 32,000 32,000 110 0.0315
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.